Morning Overview on MSN
First human trial tests gene therapy aimed at reversing cellular aging
For the roughly 80 million people worldwide living with glaucoma, daily life often means watching the world slowly close in.
A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...
Systemic candidiasis is an opportunistic fungal infection that has been difficult to treat effectively. Research published in a paper in the April edition of Cell Host & Microbe suggests that immune ...
Brain fog can be scary. It might appear innocently, like losing your car keys or forgetting what date you scheduled that appointment on. Some of this memory loss is normal—it’s just a natural side ...
A new study published in AI & Society uncovers how deeply Google’s digital ecosystem has become embedded in human cognition, memory, and identity. Through a detailed analysis of user experiences and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results